December 2025 Br J Cardiol 2025;32:152–7 doi:10.5837/bjc.2025.053
Reina Ibrahim,* Lea Nohra,* Waleed Inayat Mohamed, Kristina Nasr, Laurentia Fidella Averina Setia Santoso, Peter Raffoul, Abdallah Alkhaldi
Introduction Cardiovascular diseases (CVDs) are responsible for the demise of 17.9 million people yearly, making it the main cause of death in the world.1 According to the American Heart Association’s (AHA) 2022 report on heart disease and stroke statistics, the average yearly indirect and direct expenses of CVD in the US were an estimated $378.0 billion in 2017–2018.2 Early detection of coronary artery disease (CAD) and proper treatment can reduce mortality, and the economic burden it brings along. Although progress has been made in the diagnosis of CAD, it has been limited by the low signal-to-noise ratio of conventional imaging modalit
October 2011 Br J Cardiol 2011;18:219–22 doi:10.5837/bjc.2011.002
Sudhakar George, David Hildick-Smith
(more…)
January 2008 Br J Cardiol 2008;15:48-50
Simon EJ Janes, Joe West, Brian R Hopkinson, John T Walsh
Introduction Patients with peripheral arterial disease (PAD) have a high prevalence of modifiable risk factors for coronary artery disease (CAD).1 Consequently, they represent a suitable target for secondary prevention and there is strong evidence that this is beneficial.2–4 We aimed to establish whether people with PAD who are admitted to hospital receive equal pharmacological secondary prevention to those with CAD. Methods We prospectively recruited patients from 1st March 2003 until 1st June 2003 admitted to a vascular surgery ward (PAD) or cardiology ward (CAD) until discharge. All patients had symptomatic established disease and underw
November 2005 Br J Cardiol 2005;12:456-8
Christine Roffe, Amit Arora, Peter Crome, Richard Gray
No content available
September 2003 Br J Cardiol (Acute Interv Cardiol) 2003;10:AIC 82–AIC 88
Joseph Alex, Gurpreet S Bhamra, Alex RJ Cale, Steven C Griffin, Michael E Cowen, Levent Guvendik
No content available
July 2003 Br J Cardiol 2003;10:297-304
Frank M Sacks
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits